ABVANTEC Trademark

Trademark Overview

On Thursday, June 21, 2007, a trademark application was filed for ABVANTEC with the United States Patent and Trademark Office. The USPTO has given the ABVANTEC trademark a serial number of 79041127. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, June 21, 2017. This trademark is owned by Genmab A/S. The ABVANTEC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases, neurodegenerative diseases and cardiovascular diseases
abvantec

General Information

Serial Number79041127
Word MarkABVANTEC
Filing DateThursday, June 21, 2007
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, June 21, 2017
Registration Number3468203
Registration DateTuesday, July 15, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases, neurodegenerative diseases and cardiovascular diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 20, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenmab A/S
Party Type30 - Original Registrant
Legal Entity Type98 - Unknown
AddressDK
Party NameGenmab A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK
Party NameGenmab A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events

Event DateEvent Description
Thursday, January 11, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, January 11, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, April 21, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, February 9, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, February 9, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, January 4, 2016TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, December 10, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, December 10, 2015INVALIDATION PROCESSED
Tuesday, October 20, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 20, 2015CANCELLED SECTION 71
Monday, December 31, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 11, 2011NEW REPRESENTATIVE AT IB RECEIVED
Thursday, July 15, 2010CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, November 3, 2008FINAL DISPOSITION NOTICE SENT TO IB
Monday, November 3, 2008FINAL DISPOSITION PROCESSED
Thursday, October 16, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 15, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, April 29, 2008PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2008NOTICE OF PUBLICATION
Tuesday, March 25, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 25, 2008ASSIGNED TO LIE
Tuesday, March 11, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 10, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 10, 2008NON-FINAL ACTION E-MAILED
Monday, March 10, 2008NON-FINAL ACTION WRITTEN
Friday, February 15, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 14, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 14, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 14, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 14, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 14, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 14, 2007REFUSAL PROCESSED BY IB
Monday, August 27, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 27, 2007REFUSAL PROCESSED BY MPU
Sunday, August 26, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, August 25, 2007NON-FINAL ACTION WRITTEN
Saturday, August 25, 2007ASSIGNED TO EXAMINER
Friday, August 24, 2007NEW APPLICATION ENTERED IN TRAM
Thursday, August 23, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

abvantec diseases immune infectious other autoimmune cardiovascular neurodegenerative inflammatory syndrome deficiency